BioTechniques is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Aims and scope
    • Journal archive
    • Editorial board
    • For authors
    • Your editors: what do we do?

    Follow us on social media

  • Current issue
  • News
    • Latest news
    • Tech news
    • Events news
    • Company news

    Follow us on social media

  • Multimedia
    • Downloadable eBooks
    • Infographics
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • Features
    • Interviews
    • Opinion
    • In Focus
    • Spotlights
    • Companies
    • New products
    • Events

    Follow us on social media

  • Topics
    • Analytical chemistry
      • Biochemistry
      • Bioengineering and biophysics
      • Cancer research
      • Careers and Publishing
      • Cell and tissue biology
      • COVID-19
      • CRISPR
      • Computational biology
    • Diagnostics and preclinical
      • Drug discovery and development
      • Immunology
      • Lab design and machinery
      • Microbiology
      • Molecular biology
    • Nanomedicine
      • Neuroscience
      • PCR and sequencing
      • Plant and climate science
      • Proteomics
      • Veterinary science
      • Whole-genome studies

    Follow us on social media

  • Become a member
Our new In Focus on organ-on-a-chip technology is live! CHECK IT OUT

Cancer research

It is believed that Greek physician Hippocrates first coined the terms carcinos and carcinoma to describe tumors formed on his patients. However, earlier evidence of cancers has been found in an Egyptian textbook dating back thousands of years, describing cases of breast cancer and treatments…

Read more...

Additionally, highly sensitive sequencing techniques, such as PCR, have confirmed some of the earliest cancer cases in fossilized bone tumors. Cancer research has developed significantly since those ancient times, with many of the biggest advancements occurring over only the past 50 years, and now encapsulates multiple fields of study such as immunology and nanomedicine to understand and treat cancer’s complex mechanisms. Many technologies are leveraged in cancer research, including CRISPR and immunofluorescence.

Check out our latest news, views and articles on cutting-edge technologies driving cancer research forward below, and visit the BioTechniques journal to find recently published articles on cancer research.

  • About BioTechniques
  • Advisory Board
  • Contact Us
  • Advertising
  • Permissions
  • Whitelist Emails
Contact
Contact Us
Office info

BioTechniques is powered by Taylor & Francis Group

BioTechniques, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom

Impact Factor 2.2 | CiteScore 2.0

  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 BioTechniques